var data={"title":"Epidemiology, clinical manifestations, and diagnosis of Scedosporium and Lomentospora infections","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Epidemiology, clinical manifestations, and diagnosis of Scedosporium and Lomentospora infections</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/contributors\" class=\"contributor contributor_credentials\">Sylvia F Costa, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/contributors\" class=\"contributor contributor_credentials\">Barbara D Alexander, MD, MHS</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/contributors\" class=\"contributor contributor_credentials\">Carol A Kauffman, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/contributors\" class=\"contributor contributor_credentials\">Anna R Thorner, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Oct 24, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>During the past few decades, opportunistic fungal pathogens have become increasingly recognized as a cause of infection in severely ill or immunocompromised patients [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/1,2\" class=\"abstract_t\">1,2</a>]. Although <em>Aspergillus</em> species remain the most common mold to cause invasive infection, other mold infections are becoming more common [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/1-3\" class=\"abstract_t\">1-3</a>]. Two of these, <em>Scedosporium apiospermum</em> and <em>Lomentospora prolificans</em>, are considered major human pathogens [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/4\" class=\"abstract_t\">4</a>].</p><p>The epidemiology, clinical manifestations, and diagnosis of <em>Scedosporium</em> and <em>Lomentospora</em> infections will be reviewed here. The treatment of these infections is discussed elsewhere. (See <a href=\"topic.htm?path=treatment-of-scedosporium-and-lomentospora-infections\" class=\"medical medical_review\">&quot;Treatment of Scedosporium and Lomentospora infections&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">MYCOLOGY</span></p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h2\">Scedosporium apiospermum complex</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>S. apiospermum</em> [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/5\" class=\"abstract_t\">5</a>] is the asexual form (anamorph) of <em>Pseudallescheria boydii</em> [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/6-9\" class=\"abstract_t\">6-9</a>]. Colonies grow rapidly and have a cottony appearance on cornmeal agar; with age, the colonies become gray or brown in color (<a href=\"image.htm?imageKey=ID%2F52899\" class=\"graphic graphic_picture graphicRef52899 \">picture 1</a>). The hyphal forms appear as branching septate hyphae with a single terminal conidia, which is uninucleate and cylindrical in shape (<a href=\"image.htm?imageKey=ID%2F74529\" class=\"graphic graphic_picture graphicRef74529 \">picture 2</a>) [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/10\" class=\"abstract_t\">10</a>].</p><p>When the sexual form of <em>S. apiospermum</em> is present in culture, the organism is identified as <em>P. boydii</em>. Dark, spherical structures, known as cleistothecia, characterize the sexual form of this organism (<a href=\"image.htm?imageKey=ID%2F62333\" class=\"graphic graphic_picture graphicRef62333 \">picture 3</a>) [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/11\" class=\"abstract_t\">11</a>].</p><p><em>S. apiospermum</em> complex has been recognized to encompass several distinct species. Through the use of molecular phylogeny, the following species have been accepted as unique: <em>Pseudallescheria apiosperma </em>(anamorph <em>S. apiospermum</em>), <em>Scedosporium aurantiacum</em>, <em>P. boydii </em>(<em>Scedosporium boydii</em>), <em>Scedosporium dehoogii</em>, and <em>Pseudallescheria minutispora </em>[<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/12\" class=\"abstract_t\">12</a>]<em>.</em> Identification to the species level is of interest since the susceptibility patterns differ among members of the <em>S. apiospermum</em> complex. (See <a href=\"topic.htm?path=treatment-of-scedosporium-and-lomentospora-infections#H683955949\" class=\"medical medical_review\">&quot;Treatment of Scedosporium and Lomentospora infections&quot;, section on 'Scedosporium aurantiacum'</a>.)</p><p><em>S. aurantiacum</em> is a medically important <em>Scedosporium</em> species. It is part of the <em>S. apiospermum</em> species complex as a subset of clinical isolates previously phenotypically identified as <em>S. apiospermum. </em>It is present in the environment, and it has also been isolated from the human respiratory tract [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/13-15\" class=\"abstract_t\">13-15</a>]. <em>S. aurantiacum</em> was distinguished from <em>S. apiospermum</em> by analysis of internal transcribed spacer&ndash;restriction fragment length polymorphism (ITS-RFLP) patterns and strain typing with polymerase chain reaction fingerprinting [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/13\" class=\"abstract_t\">13</a>]. Phenotypic microarray further elucidated the difference between the two strains [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/14\" class=\"abstract_t\">14</a>].</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h2\">Lomentospora (formerly Scedosporium) prolificans</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>When first isolated as a human pathogen, <em>L. prolificans</em> was named <em>Scedosporium inflatum</em> due to its basally swollen, flask-shaped conidiogenous cells, but was later named <em>S. prolificans</em> (<a href=\"image.htm?imageKey=ID%2F63775\" class=\"graphic graphic_picture graphicRef63775 \">picture 4</a>) [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/16\" class=\"abstract_t\">16</a>]. Due to its morphologic and molecular characteristics, this organism was subsequently assigned to the genus <em>Lomentospora</em> and reclassified as <em>Lomentospora prolificans</em> [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/17-20\" class=\"abstract_t\">17-20</a>]. In contrast with <em>S. apiospermum</em>, no sexual form has been identified for <em>L. prolificans</em> [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/8\" class=\"abstract_t\">8</a>].</p><p>Colony characteristics differ based upon which nutrient agar is used [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/16,21\" class=\"abstract_t\">16,21</a>]. On Sabouraud dextrose medium, colonies are white and cottony with the reverse side appearing greenish-gray to dark green [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/16\" class=\"abstract_t\">16</a>]; colonies on potato dextrose agar are flat and olive-gray to black in color [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/10\" class=\"abstract_t\">10</a>]. Conidiogenous cells may form singly or in small clusters along the vegetative hyphae [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/11\" class=\"abstract_t\">11</a>].</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h1\">EPIDEMIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>Scedosporium</em> and <em>Lomentospora</em> species are found ubiquitously in the environment, including in soil and polluted water [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/6-9,21,22\" class=\"abstract_t\">6-9,21,22</a>]. Both <em>S. apiospermum</em> complex and <em>L. prolificans</em> have a global distribution including Europe, Australia, South America, and the United States [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/6,8,23-31\" class=\"abstract_t\">6,8,23-31</a>].</p><p>Human infection often results from inhalation of spores from the environment into the lungs or paranasal sinuses or through direct inoculation, as in a skin puncture [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/30\" class=\"abstract_t\">30</a>].</p><p>Nosocomial outbreaks of <em>Scedosporium</em> and <em>Lomentospora</em> infection in immunocompromised hosts have been linked to contaminated ambient air in hospitals [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/26,32-35\" class=\"abstract_t\">26,32-35</a>]. One such outbreak occurred at a time of hospital renovation [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/26\" class=\"abstract_t\">26</a>]. Another report involved six hematologic malignancy patients with neutropenia who were not in laminar airflow rooms or high-efficiency particulate-absorbing (HEPA) filtered rooms when they developed infection [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/33\" class=\"abstract_t\">33</a>]. <em>Lomentospora</em> isolates from four patients and two air samples were identical by polymerase chain reaction fingerprinting. After the initiation of stricter infection control practices as well as positive-pressure and HEPA filtration for hospital rooms, no further environmental contamination or clinical cases were reported in the subsequent two years of follow-up.</p><p>With the increase in the population at risk for filamentous mold infections, <em>Scedosporium </em>and <em>Lomentospora</em> infections have been reported from various locations. Surveillance studies of invasive non-<em>Aspergillus</em> mold infections in transplant recipients in the United States showed the highest rates for<em> Scedosporium</em> infection were in the south compared with other regions [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/36\" class=\"abstract_t\">36</a>].</p><p>A report from the MD Anderson Cancer Center in Houston, Texas, noted an increasing incidence of both <em>S. apiospermum</em> and <em>L. prolificans</em>, with cases of the latter seen only after the year 2000 [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/37\" class=\"abstract_t\">37</a>].</p><p>In a population-based survey from Spain, <em>Scedosporium</em> was the second most commonly detected filamentous mold in clinical samples, after <em>Aspergillus</em> spp [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/38\" class=\"abstract_t\">38</a>].</p><p>In Australia, <em>Scedosporium</em> has also been reported as the second most common etiologic agent of filamentous mold infections [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/39\" class=\"abstract_t\">39</a>], with <em>S. apiospermum </em>(35 percent), <em>L. prolificans </em>(41 percent), and <em>S. aurantiacum </em>(24 percent) identified by molecular polymorphisms in the internal transcribed spacer regions of the rDNA gene [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/15\" class=\"abstract_t\">15</a>].</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h1\">COLONIZATION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>S. apiospermum</em> is the second most common filamentous fungus isolated from the airways of cystic fibrosis patients [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/40-43\" class=\"abstract_t\">40-43</a>] and may be a stimulus for inflammatory responses, similar to that seen in allergic bronchopulmonary aspergillosis (ABPA). The presence of bacterial and fungal co-colonizers, the use of antimicrobial agents, and ABPA have been reported as possible risk factors for airway colonization of cystic fibrosis patients by <em>Scedosporium </em>species [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/44,45\" class=\"abstract_t\">44,45</a>]. <em>S. aurantiacum</em>, a member of the <em>S. apiospermum</em> complex, has also been recognized as a colonizer in cystic fibrosis patients in Australia, Germany, and France [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/44-46\" class=\"abstract_t\">44-46</a>].</p><p>Airway colonization with<em> Scedosporium</em> and <em>Lomentospora</em> species is of particular concern in lung transplant recipients because of the risk of progression to invasive infection. Two small, single-center retrospective studies reviewed the outcomes of solid organ transplant recipients with <em>Scedosporium </em>and <em>Lomentospora</em> colonization in the era of second-generation azoles [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/47,48\" class=\"abstract_t\">47,48</a>]. For lung transplant recipients, including cystic fibrosis patients, colonization prior to transplantation was reported for the majority of patients, with <em>S. apiospermum</em> complex being the most frequent colonizer. These patients were given second-generation azoles before and after transplantation, along with other antifungal agents, and most did not progress to invasive infection.</p><p>In addition to colonization of the airways, <em>L. prolificans</em> has been cultured from the external auditory canal of individuals without apparent clinical disease [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/27\" class=\"abstract_t\">27</a>].</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h1\">CLINICAL MANIFESTATIONS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>Scedosporium</em> and <em>Lomentospora</em> species can cause localized infection in immunocompetent hosts following trauma or surgery, or severe disseminated disease in immunocompromised hosts. The two species are discussed separately below.</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h2\">S. apiospermum infections</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>S. apiospermum</em> complex is mainly associated with infections in immunocompromised hosts, although some localized infections have been described in immunocompetent hosts.</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h3\">Respiratory tract</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>S. apiospermum</em> infection frequently involves the respiratory tract in patients with chronic granulomatous disease [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/49\" class=\"abstract_t\">49</a>], chronic glucocorticoid use [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/50\" class=\"abstract_t\">50</a>], hematopoietic cell transplantation [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/29,51-55\" class=\"abstract_t\">29,51-55</a>], hematologic malignancy, or solid organ transplantation [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/28,29,56-60\" class=\"abstract_t\">28,29,56-60</a>].</p><p>The initial presentation typically includes fever, cough, sputum production, pleuritic chest pain, tachypnea, and malaise. <em>Scedosporium</em> infection may present as a localized pulmonary process or may disseminate from the lungs to multiple organs, including brain and skin [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/29,56,57\" class=\"abstract_t\">29,56,57</a>].</p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h3\">Keratitis and endophthalmitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Ophthalmologic <em>Scedosporium</em> infections can present as a localized corneal process or as endogenous endophthalmitis in the setting of disseminated disease.</p><p>Fungal keratitis caused by <em>Scedosporium</em> spp has been reported in immunocompetent hosts with or without a history of overt ocular injury [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/61-65\" class=\"abstract_t\">61-65</a>]. Patients experience eye pain, photophobia, foreign body sensation, conjunctival or corneal erythema, tearing, and changes in visual acuity. <em>Scedosporium</em> corneal infections can lead to frank corneal ulceration, abrasion, perforation, infiltrate, and anterior chamber hypopyon. Corneal scrapings or biopsy provide the diagnosis. (See <a href=\"topic.htm?path=treatment-of-scedosporium-and-lomentospora-infections\" class=\"medical medical_review\">&quot;Treatment of Scedosporium and Lomentospora infections&quot;</a>.)</p><p>In contrast, endogenous endophthalmitis due to <em>S. apiospermum</em> occurs after hematogenous dissemination in immunocompromised hosts [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/56,66-73\" class=\"abstract_t\">56,66-73</a>]. Presenting symptoms include eye pain, photosensitivity, and decreased visual acuity. Funduscopic examination reveals exudates and a hazy vitreous; a hemorrhagic necrotizing chorioretinitis has been noted at autopsy [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/74\" class=\"abstract_t\">74</a>].</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h3\">Central nervous system</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>S. apiospermum</em> has been associated with brain abscesses in both immunocompetent [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/75,76\" class=\"abstract_t\">75,76</a>] and immunocompromised patients [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/56,77,78\" class=\"abstract_t\">56,77,78</a>].</p><p><em>S. apiospermum</em> brain abscesses have been described in individuals surviving near-drowning episodes [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/76,79-82\" class=\"abstract_t\">76,79-82</a>]. The portal of entry may be directly through the sinuses with contiguous spread or via hematogenous dissemination from the lungs. Patients are obtunded, febrile, and often have severe hypoxia related to the near-drowning event.</p><p>Brain abscesses from hematogenous dissemination of <em>S. apiospermum</em> have been described in immunocompromised patients, particularly in recipients of hematopoietic cell [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/77,83,84\" class=\"abstract_t\">77,83,84</a>] and solid organ [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/56,71,72,85,86\" class=\"abstract_t\">56,71,72,85,86</a>] transplants. Neurologic findings include headache, confusion, disorientation, agitation, cognitive decline, progressive lethargy, hemiparesis, and seizures.</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h3\">Skin, soft tissue, and bone</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Skin lesions secondary to <em>S. apiospermum</em> often occur in the setting of disseminated infection [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/29,56,85,87-90\" class=\"abstract_t\">29,56,85,87-90</a>]. Lesions may appear as nodules or as erythematous to purple papules or bullae, which may develop a necrotic center. Occasionally, a pattern of lymphangitic spread may be seen with multiple nodules and pustules.</p><p>Localized soft tissue infections [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/60,90,91\" class=\"abstract_t\">60,90,91</a>] and osteomyelitis [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/75,92-94\" class=\"abstract_t\">75,92-94</a>] due to <em>S. apiospermum</em> [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/23,95-101\" class=\"abstract_t\">23,95-101</a>] have also been reported in the setting of trauma. The extremities are most often involved, although cases involving the spine or cranium have also been described.</p><p>A retrospective review of 145 cases of osteoarticular infections in children and adults between 1970 and 2013 revealed that <em>Scedosporium</em> species were implicated in the majority of non-<em>Aspergillus</em> filamentous mold infections [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/102\" class=\"abstract_t\">102</a>]. <em>S. apiospermum</em> constituted 33 percent of the cases, while <em>L. prolificans</em> constituted 16 percent. Immunocompromised patients accounted for 62 percent of the patients with non-<em>Aspergillus</em> osteoarticular infections.</p><p>Eumycetoma of the foot due to <em>S. apiospermum</em> complex has also been reported [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/103\" class=\"abstract_t\">103</a>].</p><p class=\"headingAnchor\" id=\"H13\"><span class=\"h3\">Disseminated infection</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Disseminated disease is defined as the infection of two or more noncontiguous body sites <span class=\"nowrap\">and/or</span> bloodstream infection [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/89,104,105\" class=\"abstract_t\">89,104,105</a>]. Dissemination is known to readily occur, particularly in severely immunosuppressed patients, and can cause shock and multiorgan failure [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/57\" class=\"abstract_t\">57</a>].</p><p class=\"headingAnchor\" id=\"H14\"><span class=\"h3\">Other</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>S. apiospermum</em> has also been implicated as a cause of sinusitis in immunocompromised hosts [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/56,106,107\" class=\"abstract_t\">56,106,107</a>], lymphadenitis in an immunocompetent host [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/108\" class=\"abstract_t\">108</a>], and mycotic aneurysm in a kidney transplant recipient [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/109\" class=\"abstract_t\">109</a>]. Endocarditis due to <em>S. apiospermum</em> has been reported in an orthotopic heart transplant recipient [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/110\" class=\"abstract_t\">110</a>].</p><p class=\"headingAnchor\" id=\"H334471836\"><span class=\"h2\">S. aurantiacum infections</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>As noted above, <em>S. aurantiacum</em> has been recognized as a medically important <em>Scedosporium</em> species that is part of the <em>S. apiospermum</em> species complex. Most cases of <em>S. aurantiacum</em> infection have been reported from Australia, where it has typically been associated with chronic lung disease [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/15\" class=\"abstract_t\">15</a>]. A few invasive cases have been described.</p><p class=\"headingAnchor\" id=\"H15\"><span class=\"h2\">L. prolificans infections</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The first described clinical case of <em>L. prolificans</em> infection was in 1984 in an immunocompetent six-year-old boy who developed osteomyelitis of the foot after penetrating trauma [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/16\" class=\"abstract_t\">16</a>]. Since then, multiple cases with different clinical presentations have been reported in the literature [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/24,25,27,30,111\" class=\"abstract_t\">24,25,27,30,111</a>].</p><p class=\"headingAnchor\" id=\"H16\"><span class=\"h3\">Respiratory tract</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Infection of the respiratory tract with<em> L. prolificans</em> has been reported mainly in patients with immunosuppression [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/25,28,29,111\" class=\"abstract_t\">25,28,29,111</a>]. Underlying conditions have included malignancy (usually hematologic), solid organ or hematopoietic cell transplantation, chronic immunosuppressive therapy, chronic corticosteroid treatment, and AIDS. The usual presenting symptoms have included productive cough, dyspnea, and fever, and the organism was recovered from either sputum or bronchoalveolar lavage specimens. (See <a href=\"topic.htm?path=treatment-of-scedosporium-and-lomentospora-infections\" class=\"medical medical_review\">&quot;Treatment of Scedosporium and Lomentospora infections&quot;</a>.)</p><p>In a group of lung transplant recipients, <em>L. prolificans</em> was repeatedly cultured from bronchoalveolar lavage fluid, often together with <em>S. apiospermum</em> [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/28\" class=\"abstract_t\">28</a>]. The majority of these patients had the following characteristics, which may have predisposed them to infection: bacterial or cytomegalovirus pneumonitis, rejection episodes requiring pulse corticosteroids, and structural changes in their airways. Eradication of <em>L. prolificans</em> was unsuccessful in the majority of patients.</p><p class=\"headingAnchor\" id=\"H17\"><span class=\"h3\">Keratitis and endophthalmitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>L. prolificans</em> has been implicated as an agent of fungal keratitis [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/112-115\" class=\"abstract_t\">112-115</a>] and endophthalmitis [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/74,111,116-118\" class=\"abstract_t\">74,111,116-118</a>]. Trauma or surgery often serves as the portal of entry for the fungus.</p><p>Keratitis may present as foreign body sensation, lacrimation, and discharge. The cases described are in patients who either had a retained contact lens (which led to breakdown in the corneal epithelium) or who had experienced scleral necrosis after pterygium surgery with adjunctive beta-irradiation. If the corneal epithelium is invaded by the fungus, aggressive surgical debridement and antifungal therapy is needed to avoid loss of visual acuity or enucleation.</p><p>Both exogenous and endogenous endophthalmitis have been reported, the latter in the setting of disseminated infection. Changes in visual acuity or other visual disturbances are reported, with fundoscopic examination revealing vitreous turbidity and white retinal infiltrates or exudates. Progressive visual loss is common.</p><p class=\"headingAnchor\" id=\"H18\"><span class=\"h3\">Central nervous system</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Central nervous system infection with <em>L. prolificans</em> has been reported and has an extremely high mortality rate [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/24,29,111,119-124\" class=\"abstract_t\">24,29,111,119-124</a>]. Most cases have occurred in the setting of disseminated infection. Manifestations have included meningitis, meningoencephalitis, and cerebral abscesses. Clinical features include headache, altered mental status, meningeal signs, focal neurologic deficits, seizures, or acute neurologic deterioration.</p><p class=\"headingAnchor\" id=\"H19\"><span class=\"h3\">Skin, soft tissue, and bone infections</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Localized musculoskeletal infections, such as arthritis or osteomyelitis due to <em>L. prolificans</em> have been reported [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/16,27,30,102,111,125-127\" class=\"abstract_t\">16,27,30,102,111,125-127</a>]. The most frequent predisposing event is trauma, either penetrating or nonpenetrating, to the affected extremity. Initial presentations include laceration or cellulitis at the site, with progression to joint effusion, inflammation, and tenderness; some patients also have low-grade fever. Those with bone involvement have symptoms and signs of inflammation as well as imaging studies consistent with osteomyelitis.</p><p class=\"headingAnchor\" id=\"H1992817663\"><span class=\"h3\">Endocarditis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Cases of endocarditis due to <em>L. prolificans</em> have been reported in patients with preexisting cardiac abnormalities <span class=\"nowrap\">and/or</span> immunosuppression [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/123,128-131\" class=\"abstract_t\">123,128-131</a>]. The mortality is high.</p><p class=\"headingAnchor\" id=\"H20\"><span class=\"h3\">Disseminated infection</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The most commonly reported presentation of <em>L. prolificans</em> infection is disseminated infection [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/24-26,29,31,74,111,118-120,122,132-137\" class=\"abstract_t\">24-26,29,31,74,111,118-120,122,132-137</a>]. Fungemia is more common with <em>L. prolificans</em> than with <em>S. apiospermum </em>complex [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/29\" class=\"abstract_t\">29</a>]. In three case series, positive blood cultures were reported in 80 percent (24 of 30), 75 percent (12 of 16), and 100 percent (6 of 6) of <em>L. prolificans</em> cases, respectively [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/24,25,31\" class=\"abstract_t\">24,25,31</a>].</p><p>Predisposing underlying risk factors for fungemia include neutropenia, hematopoietic cell transplant, solid organ transplant, malignancy, and AIDS [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/25,29,136\" class=\"abstract_t\">25,29,136</a>]. In a series of neutropenic patients with hematologic malignancies, the most frequent clinical manifestation of disseminated <em>L. prolificans</em> infection was fever [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/24\" class=\"abstract_t\">24</a>]. Pulmonary symptoms, such as dyspnea, cough, and infiltrates on chest radiographs, were also common. Other symptoms and signs included skin lesions, altered mental status, visual changes, renal failure, and septic shock.</p><p>Disseminated infection is associated with very high mortality rates. (See <a href=\"topic.htm?path=treatment-of-scedosporium-and-lomentospora-infections#H31\" class=\"medical medical_review\">&quot;Treatment of Scedosporium and Lomentospora infections&quot;, section on 'Prognosis'</a>.)</p><p class=\"headingAnchor\" id=\"H863185604\"><span class=\"h1\">DIAGNOSIS</span></p><p class=\"headingAnchor\" id=\"H1119797472\"><span class=\"h2\">Approach to diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The approach to diagnosis is individualized based upon various patient-specific factors, including site and severity of infection, as well as the immune status of the host. Whenever possible, and especially for immunocompromised hosts <span class=\"nowrap\">and/or</span> for patients with severe disease, clinicians should aggressively pursue a diagnosis when <em>Scedosporium</em> infection is suspected.</p><p>Proven invasive mold infection is defined as [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/138\" class=\"abstract_t\">138</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Histopathologic examination revealing tissue invasion and a culture result positive for mold</p><p/><p class=\"bulletIndent1\"><strong>OR</strong></p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Clinical or radiographic findings consistent with infection and a culture positive for mold obtained via sterile technique from a normally sterile site</p><p/><p>Histopathologic examination is helpful for determining that an invasive mold infection is present, but it is not possible to establish the causative pathogen without culture because various hyaline molds have a similar appearance. For this reason, culture is an essential part of the diagnostic evaluation. Culture is also important for testing in vitro susceptibility since <em>Scedosporium</em> spp, particularly <em>L. prolificans</em>, can be resistant to multiple antifungal agents. (See <a href=\"topic.htm?path=treatment-of-scedosporium-and-lomentospora-infections#H8\" class=\"medical medical_review\">&quot;Treatment of Scedosporium and Lomentospora infections&quot;, section on 'Susceptibility testing'</a> and <a href=\"topic.htm?path=antifungal-susceptibility-testing\" class=\"medical medical_review\">&quot;Antifungal susceptibility testing&quot;</a>.)</p><p>A serum beta-D-glucan test, which detects a cell wall component of many fungi, and a serum galactomannan antigen, which is fairly specific for <em>Aspergillus</em> spp, can be helpful if a mold infection is suspected. (See <a href=\"topic.htm?path=diagnosis-of-invasive-aspergillosis#H1064486465\" class=\"medical medical_review\">&quot;Diagnosis of invasive aspergillosis&quot;, section on 'Beta-D-glucan assay'</a> and <a href=\"topic.htm?path=diagnosis-of-invasive-aspergillosis#H1064486430\" class=\"medical medical_review\">&quot;Diagnosis of invasive aspergillosis&quot;, section on 'Galactomannan antigen detection'</a>.)</p><p class=\"headingAnchor\" id=\"H1119797400\"><span class=\"h2\">Diagnostic techniques</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Multiple diagnostic techniques can be used to aid with the diagnosis of <em>Scedosporium</em> infections; these are summarized in the following table (<a href=\"image.htm?imageKey=ID%2F52154\" class=\"graphic graphic_table graphicRef52154 \">table 1</a>) and discussed in detail below.</p><p class=\"headingAnchor\" id=\"H863185641\"><span class=\"h3\">Histopathology</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Specimens from potentially sterile sources, including tissue biopsies, aspirates, and bronchoalveolar lavage, may be used for examination for invasive mold infection [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/139\" class=\"abstract_t\">139</a>]. Periodic-acid Schiff or Gomori methenamine silver stains can be used for better visualization of fungi in tissue. Diagnosis of an invasive mold infection may be made when septate hyphae are identified in an area of inflammation, granulomas, or necrosis. Septate, hyaline (nonpigmented) branching hyphae at a 45&ordm; angle are consistent with <em>Scedosporium</em> infection but are also seen with other hyaline molds, such as <em>Aspergillus</em> and <em>Fusarium</em> spp [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/11\" class=\"abstract_t\">11</a>]. (See <a href=\"#H863186356\" class=\"local\">'Differential diagnosis'</a> below.)</p><p>One histologic feature that distinguishes <em>Scedosporium</em> infection from <em>Aspergillus</em> infection in vivo is the presence of adventitious forms. These unicellular forms may invade the wall of blood vessels and allow sporulation of the fungus directly into the blood, resulting in positive blood cultures [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/2\" class=\"abstract_t\">2</a>]. Although this feature is not characteristic of <em>Aspergillus</em>, it may be seen with other hyaline molds. The overall histologic similarity between these organisms therefore necessitates culture of specimens in order to definitively identify the infecting pathogen.</p><p class=\"headingAnchor\" id=\"H863185689\"><span class=\"h3\">Culture</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The definitive diagnosis of <em>Scedosporium</em> infection can be established through culture but must be interpreted in its clinical context. Cultures of corneal scrapings or corneal biopsy [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/63\" class=\"abstract_t\">63</a>], skin [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/56,85\" class=\"abstract_t\">56,85</a>], soft tissue [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/90\" class=\"abstract_t\">90</a>], bone [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/30,125,133\" class=\"abstract_t\">30,125,133</a>], joint fluid [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/27\" class=\"abstract_t\">27</a>], and brain abscesses [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/76,80\" class=\"abstract_t\">76,80</a>] have yielded <em>Scedosporium</em> in patients with localized and disseminated infection. Alternatively, a positive culture from the respiratory tract may simply represent colonization [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/40-42\" class=\"abstract_t\">40-42</a>] and must be interpreted carefully. However, in a patient with suggestive clinical findings, isolation from the respiratory tract provides a probable diagnosis of scedosporiosis [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/25,28,29,49,51-54,56,59\" class=\"abstract_t\">25,28,29,49,51-54,56,59</a>]. (See <a href=\"#H6\" class=\"local\">'Colonization'</a> above.)</p><p>Blood cultures are also useful for detection of <em>Scedosporium</em> in cases of disseminated disease. In a case series, 52 of 72 patients (72 percent) with disseminated <em>L. prolificans</em> infection had positive blood cultures [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/111\" class=\"abstract_t\">111</a>]. Although <em>Scedosporium</em> can be isolated in commercial broth enrichment media, specialized fungal media, such as the Myco-F-Lytic bottle or the lysis centrifugation method, are suggested when fungemia is suspected [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/140,141\" class=\"abstract_t\">140,141</a>].</p><p class=\"headingAnchor\" id=\"H863186180\"><span class=\"h2\">Molecular techniques</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Molecular methods have been developed for the identification and differentiation of molds. Polymerase chain reaction (PCR) technology and sequencing [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/43,140,142,143\" class=\"abstract_t\">43,140,142,143</a>] provide rapid identification of molds and have been used for epidemiologic purposes, such as DNA fingerprinting to evaluate possible outbreaks of <em>L. prolificans</em> [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/33,143\" class=\"abstract_t\">33,143</a>]. Some institutions have developed their own PCRs targeting internal transcribed spacer (ITS) sequence polymorphisms for the identification of the different <em>Scedosporium </em>and<em> Lomentospora </em>species in clinical specimens [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/45,144-147\" class=\"abstract_t\">45,144-147</a>]. Unfortunately, these tools are not widely available in most clinical laboratories at this time.</p><p class=\"headingAnchor\" id=\"H863186274\"><span class=\"h2\">Antigen detection</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Beta-D-glucan is a cell wall constituent of many fungi, including <em>Scedosporium</em> [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/148\" class=\"abstract_t\">148</a>]. Detection of beta-D<strong>-</strong>glucan in the serum of patients with suspected invasive mycoses <span class=\"nowrap\">and/or</span> fungemia, including <em>Aspergillus</em>, <em>Candida</em>, <em>Fusarium</em>, <em>Trichosporon</em>, and <em>Acremonium</em> can be a useful test [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/149-152\" class=\"abstract_t\">149-152</a>]. The diagnostic accuracy of this test for <em>Scedosporium</em> infections is not yet known.</p><p class=\"headingAnchor\" id=\"H3611839638\"><span class=\"h2\">MALDI-TOF</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Matrix-assisted laser <span class=\"nowrap\">desorption/ionization</span> time-of-flight (MALDI-TOF) mass spectrometry has emerged as an additional tool for the rapid identification of molds [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/153-156\" class=\"abstract_t\">153-156</a>]. MALDI-TOF is able to identify and discriminate among different <em>Scedosporium</em> and <em>Lomentospora</em> species. Some clinical laboratories have developed extensive fungal databases for this purpose, and commercial MALDI-TOF systems with fungal databases are available in some reference laboratories.</p><p class=\"headingAnchor\" id=\"H863186356\"><span class=\"h1\">DIFFERENTIAL DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>All hyaline molds, including <em>Aspergillus</em>, <em>Scedosporium</em>, <em>Lomentospora</em>, <em>Fusarium</em>, <em>Acremonium</em>, and <em>Paecilomyces</em> exhibit similar appearance in clinical specimens by microscopic examination [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/2,157\" class=\"abstract_t\">2,157</a>]. Septated, nonpigmented hyphae and branching at 45&ordm; angles render them indistinguishable from one another, and correlation with culture results is needed for definitive identification [<a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/139\" class=\"abstract_t\">139</a>]. (See <a href=\"#H863185689\" class=\"local\">'Culture'</a> above.)</p><p>There is substantial overlap in the clinical manifestations that can occur with infections caused by any of the hyaline molds.</p><p class=\"headingAnchor\" id=\"H21\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>During the past few decades, opportunistic fungal pathogens have become increasingly recognized as a cause of infection in severely ill or immunocompromised patients. Although <em>Aspergillus</em> species remain the most common mold to cause invasive infection, other molds are becoming more common. Two of these, <em>Scedosporium apiospermum</em> complex and <em>Lomentospora</em> <em>prolificans</em>, are considered major human pathogens. (See <a href=\"#H1\" class=\"local\">'Introduction'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><em>Scedosporium</em> and <em>Lomentospora</em> species are commonly found in soil and polluted water and have a global distribution. (See <a href=\"#H5\" class=\"local\">'Epidemiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><em>Scedosporium</em> and <em>Lomentospora</em> are mainly associated with infections in immunocompromised hosts, although some localized infections have been described in immunocompetent hosts. Reported infections caused by these pathogens include pneumonia, keratitis, endophthalmitis, central nervous system infections, soft tissue infections, and disseminated disease. (See <a href=\"#H7\" class=\"local\">'Clinical manifestations'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The approach to diagnosis is individualized based upon various patient-specific factors, including site and severity of infection, as well as the immune status of the host (<a href=\"image.htm?imageKey=ID%2F52154\" class=\"graphic graphic_table graphicRef52154 \">table 1</a>). Whenever possible, and especially for immunocompromised hosts <span class=\"nowrap\">and/or</span> for patients with severe disease, clinicians should aggressively pursue a diagnosis when <em>Scedosporium</em> or <em>Lomentospora</em> infection is suspected. (See <a href=\"#H1119797472\" class=\"local\">'Approach to diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Histologically, <em>Scedosporium </em>and <em>Lomentospora</em>, with septated, nonpigmented hyphae branching at 45&ordm; angles, resemble the other hyaline molds such as <em>Aspergillus</em> and <em>Fusarium</em>. Definite diagnosis is made through culture. Culture is also important for testing in vitro susceptibility since these pathogens, particularly <em>L. prolificans</em>, can be resistant to multiple antifungal agents. (See <a href=\"#H863185604\" class=\"local\">'Diagnosis'</a> above.)</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/1\" class=\"nounderline abstract_t\">Groll AH, Walsh TJ. Uncommon opportunistic fungi: new nosocomial threats. Clin Microbiol Infect 2001; 7 Suppl 2:8.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/2\" class=\"nounderline abstract_t\">Perfect JR, Schell WA. The new fungal opportunists are coming. Clin Infect Dis 1996; 22 Suppl 2:S112.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/3\" class=\"nounderline abstract_t\">Husain S, Alexander BD, Munoz P, et al. Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi. Clin Infect Dis 2003; 37:221.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/4\" class=\"nounderline abstract_t\">Panackal AA, Marr KA. Scedosporium/Pseudallescheria infections. Semin Respir Crit Care Med 2004; 25:171.</a></li><li class=\"breakAll\">Castellani A, Chalmers AJ. Scedosporium apiospermum. In: Manual of Tropical Medicine, 3rd ed, Baillere, Tindall &amp; Cox, London 1919.</li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/6\" class=\"nounderline abstract_t\">McGinnis MR, Padhye AA, Ajello L. Pseudallescheria Negroni et Fischer, 1943 and its later synonym Petriellidium Malloch, 1970. Mycotaxon 1982; 14:94.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/7\" class=\"nounderline abstract_t\">de Hoog GS, Marvin-Sikkema FD, Lahpoor GA, et al. Ecology and physiology of the emerging opportunistic fungi Pseudallescheria boydii and Scedosporium prolificans. Mycoses 1994; 37:71.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/8\" class=\"nounderline abstract_t\">Rainer J, de Hoog GS, Wedde M, et al. Molecular variability of Pseudallescheria boydii, a neurotropic opportunist. J Clin Microbiol 2000; 38:3267.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/9\" class=\"nounderline abstract_t\">Gilgado F, Cano J, Gen&eacute; J, Guarro J. Molecular phylogeny of the Pseudallescheria boydii species complex: proposal of two new species. J Clin Microbiol 2005; 43:4930.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/10\" class=\"nounderline abstract_t\">Salkin IF, McGinnis MR, Dykstra MJ, Rinaldi MG. Scedosporium inflatum, an emerging pathogen. J Clin Microbiol 1988; 26:498.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/11\" class=\"nounderline abstract_t\">Walsh TJ, Groll A, Hiemenz J, et al. Infections due to emerging and uncommon medically important fungal pathogens. Clin Microbiol Infect 2004; 10 Suppl 1:48.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/12\" class=\"nounderline abstract_t\">Lackner M, de Hoog GS, Verweij PE, et al. Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species. Antimicrob Agents Chemother 2012; 56:2635.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/13\" class=\"nounderline abstract_t\">Delhaes L, Harun A, Chen SC, et al. Molecular typing of Australian Scedosporium isolates showing genetic variability and numerous S. aurantiacum. Emerg Infect Dis 2008; 14:282.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/14\" class=\"nounderline abstract_t\">Kaur J, Duan SY, Vaas LA, et al. Phenotypic profiling of Scedosporium aurantiacum, an opportunistic pathogen colonizing human lungs. PLoS One 2015; 10:e0122354.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/15\" class=\"nounderline abstract_t\">Heath CH, Slavin MA, Sorrell TC, et al. Population-based surveillance for scedosporiosis in Australia: epidemiology, disease manifestations and emergence of Scedosporium aurantiacum infection. Clin Microbiol Infect 2009; 15:689.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/16\" class=\"nounderline abstract_t\">Malloch D, Salkin IF. A new species of Scedosporium associated with osteomyelitis in humans. Mycotaxon 1984; 21:247.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/17\" class=\"nounderline abstract_t\">Lackner M, Sybren de Hoog, Yang L, et al. Proposed nomenclature for Pseudallescheria, Scedosporium and related genera. Fungal Diversity 2014; 67:1.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/18\" class=\"nounderline abstract_t\">Lennon PA, Cooper CR Jr, Salkin IF, Lee SB. Ribosomal DNA internal transcribed spacer analysis supports synonomy of Scedosporium inflatum and Lomentospora prolificans. J Clin Microbiol 1994; 32:2413.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/19\" class=\"nounderline abstract_t\">Gueho E, Hoog GS de. Taxonomy of the medical species of Pseudallescheria and Scedosporium. J Mycol Med 1991; 1:3.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/20\" class=\"nounderline abstract_t\">Hennebert GL, Desai BG. Lomentospora prolificansa New Hypohomycete from Greenhouse Soil. Mycotaxo 1974; 1:45.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/21\" class=\"nounderline abstract_t\">Hennebert GI, Desai BG. Lomentospora prolificans, a new hyphomycete from greenhous soil. Mycotaxon 1974; 1:44.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/22\" class=\"nounderline abstract_t\">Summerbell RC, Krajden S, Kane J. Potted plants in hospitals as reservoirs of pathogenic fungi. Mycopathologia 1989; 106:13.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/23\" class=\"nounderline abstract_t\">Travis LB, Roberts GD, Wilson WR. Clinical significance of Pseudallescheria boydii: a review of 10 years' experience. Mayo Clin Proc 1985; 60:531.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/24\" class=\"nounderline abstract_t\">Berenguer J, Rodr&iacute;guez-Tudela JL, Richard C, et al. Deep infections caused by Scedosporium prolificans. A report on 16 cases in Spain and a review of the literature. Scedosporium Prolificans Spanish Study Group. Medicine (Baltimore) 1997; 76:256.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/25\" class=\"nounderline abstract_t\">Idigoras P, P&eacute;rez-Trallero E, Pi&ntilde;eiro L, et al. Disseminated infection and colonization by Scedosporium prolificans: a review of 18 cases, 1990-1999. Clin Infect Dis 2001; 32:E158.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/26\" class=\"nounderline abstract_t\">Alvarez M, Lopez Ponga B, Rayon C, et al. Nosocomial outbreak caused by Scedosporium prolificans (inflatum): four fatal cases in leukemic patients. J Clin Microbiol 1995; 33:3290.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/27\" class=\"nounderline abstract_t\">Wood GM, McCormack JG, Muir DB, et al. Clinical features of human infection with Scedosporium inflatum. Clin Infect Dis 1992; 14:1027.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/28\" class=\"nounderline abstract_t\">Tamm M, Malouf M, Glanville A. Pulmonary scedosporium infection following lung transplantation. Transpl Infect Dis 2001; 3:189.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/29\" class=\"nounderline abstract_t\">Husain S, Mu&ntilde;oz P, Forrest G, et al. Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome. Clin Infect Dis 2005; 40:89.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/30\" class=\"nounderline abstract_t\">Wilson CM, O'Rourke EJ, McGinnis MR, Salkin IF. Scedosporium inflatum: clinical spectrum of a newly recognized pathogen. J Infect Dis 1990; 161:102.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/31\" class=\"nounderline abstract_t\">Revankar SG, Patterson JE, Sutton DA, et al. Disseminated phaeohyphomycosis: review of an emerging mycosis. Clin Infect Dis 2002; 34:467.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/32\" class=\"nounderline abstract_t\">del Palacio A, Garau M, Amor E, et al. Case reports. Transient colonization with Scedosporium prolificans. Report of four cases in Madrid. Mycoses 2001; 44:321.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/33\" class=\"nounderline abstract_t\">Guerrero A, Torres P, Duran MT, et al. Airborne outbreak of nosocomial Scedosporium prolificans infection. Lancet 2001; 357:1267.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/34\" class=\"nounderline abstract_t\">Simarro E, Mar&iacute;n F, Morales A, et al. Fungemia due to Scedosporium prolificans: a description of two cases with fatal outcome. Clin Microbiol Infect 2001; 7:645.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/35\" class=\"nounderline abstract_t\">Cooley L, Spelman D, Thursky K, Slavin M. Infection with Scedosporium apiospermum and S. prolificans, Australia. Emerg Infect Dis 2007; 13:1170.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/36\" class=\"nounderline abstract_t\">Park BJ, Pappas PG, Wannemuehler KA, et al. Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006. Emerg Infect Dis 2011; 17:1855.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/37\" class=\"nounderline abstract_t\">Lamaris GA, Chamilos G, Lewis RE, et al. Scedosporium infection in a tertiary care cancer center: a review of 25 cases from 1989-2006. Clin Infect Dis 2006; 43:1580.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/38\" class=\"nounderline abstract_t\">Alastruey-Izquierdo A, Mellado E, Pel&aacute;ez T, et al. Population-based survey of filamentous fungi and antifungal resistance in Spain (FILPOP Study). Antimicrob Agents Chemother 2013; 57:3380.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/39\" class=\"nounderline abstract_t\">Slavin M, van Hal S, Sorrell TC, et al. Invasive infections due to filamentous fungi other than Aspergillus: epidemiology and determinants of mortality. Clin Microbiol Infect 2015; 21:490.e1.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/40\" class=\"nounderline abstract_t\">Cimon B, Carr&egrave;re J, Vinatier JF, et al. Clinical significance of Scedosporium apiospermum in patients with cystic fibrosis. Eur J Clin Microbiol Infect Dis 2000; 19:53.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/41\" class=\"nounderline abstract_t\">Symoens F, Knoop C, Schrooyen M, et al. Disseminated Scedosporium apiospermum infection in a cystic fibrosis patient after double-lung transplantation. J Heart Lung Transplant 2006; 25:603.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/42\" class=\"nounderline abstract_t\">Defontaine A, Zouhair R, Cimon B, et al. Genotyping study of Scedosporium apiospermum isolates from patients with cystic fibrosis. J Clin Microbiol 2002; 40:2108.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/43\" class=\"nounderline abstract_t\">Williamson EC, Speers D, Arthur IH, et al. Molecular epidemiology of Scedosporium apiospermum infection determined by PCR amplification of ribosomal intergenic spacer sequences in patients with chronic lung disease. J Clin Microbiol 2001; 39:47.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/44\" class=\"nounderline abstract_t\">Schwarz C, Brandt C, Antweiler E, et al. Prospective multicenter German study on pulmonary colonization with Scedosporium /Lomentospora species in cystic fibrosis: Epidemiology and new association factors. PLoS One 2017; 12:e0171485.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/45\" class=\"nounderline abstract_t\">Blyth CC, Middleton PG, Harun A, et al. Clinical associations and prevalence of Scedosporium spp. in Australian cystic fibrosis patients: identification of novel risk factors? Med Mycol 2010; 48 Suppl 1:S37.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/46\" class=\"nounderline abstract_t\">Zouhair R, Rougeron A, Razafimandimby B, et al. Distribution of the different species of the Pseudallescheria boydii/Scedosporium apiospermum complex in French patients with cystic fibrosis. Med Mycol 2013; 51:603.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/47\" class=\"nounderline abstract_t\">Parize P, Boussaud V, Poinsignon V, et al. Clinical outcome of cystic fibrosis patients colonized by Scedosporium species following lung transplantation: A single-center 15-year experience. Transpl Infect Dis 2017; 19.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/48\" class=\"nounderline abstract_t\">Johnson LS, Shields RK, Clancy CJ. Epidemiology, clinical manifestations, and outcomes of Scedosporium infections among solid organ transplant recipients. Transpl Infect Dis 2014; 16:578.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/49\" class=\"nounderline abstract_t\">Jabado N, Casanova JL, Haddad E, et al. Invasive pulmonary infection due to Scedosporium apiospermum in two children with chronic granulomatous disease. Clin Infect Dis 1998; 27:1437.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/50\" class=\"nounderline abstract_t\">Horr&eacute; R, Jovani&#263; B, Marklein G, et al. Fatal pulmonary scedosporiosis. Mycoses 2003; 46:418.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/51\" class=\"nounderline abstract_t\">Garc&iacute;a-Arata MI, Otero MJ, Zome&ntilde;o M, et al. Scedosporium apiospermum pneumonia after autologous bone marrow transplantation. Eur J Clin Microbiol Infect Dis 1996; 15:600.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/52\" class=\"nounderline abstract_t\">Klopfenstein KJ, Rosselet R, Termuhlen A, Powell D. Successful treatment of Scedosporium pneumonia with voriconazole during AML therapy and bone marrow transplantation. Med Pediatr Oncol 2003; 41:494.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/53\" class=\"nounderline abstract_t\">Nomded&eacute;u J, Brunet S, Martino R, et al. Successful treatment of pneumonia due to Scedosporium apiospermum with itraconazole: case report. Clin Infect Dis 1993; 16:731.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/54\" class=\"nounderline abstract_t\">Goldberg SL, Geha DJ, Marshall WF, et al. Successful treatment of simultaneous pulmonary Pseudallescheria boydii and Aspergillus terreus infection with oral itraconazole. Clin Infect Dis 1993; 16:803.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/55\" class=\"nounderline abstract_t\">Marr KA, Carter RA, Crippa F, et al. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002; 34:909.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/56\" class=\"nounderline abstract_t\">Castiglioni B, Sutton DA, Rinaldi MG, et al. Pseudallescheria boydii (Anamorph Scedosporium apiospermum). Infection in solid organ transplant recipients in a tertiary medical center and review of the literature. Medicine (Baltimore) 2002; 81:333.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/57\" class=\"nounderline abstract_t\">Raj R, Frost AE. Scedosporium apiospermum fungemia in a lung transplant recipient. Chest 2002; 121:1714.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/58\" class=\"nounderline abstract_t\">Patterson TF, Andriole VT, Zervos MJ, et al. The epidemiology of pseudallescheriasis complicating transplantation: nosocomial and community-acquired infection. Mycoses 1990; 33:297.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/59\" class=\"nounderline abstract_t\">Perlroth MG, Miller J. Pseudoallescheria boydii pneumonia and empyema: a rare complication of heart transplantation cured with voriconazole. J Heart Lung Transplant 2004; 23:647.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/60\" class=\"nounderline abstract_t\">Talbot TR, Hatcher J, Davis SF, et al. Scedosporium apiospermum pneumonia and sternal wound infection in a heart transplant recipient. Transplantation 2002; 74:1645.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/61\" class=\"nounderline abstract_t\">D&iacute;az-Valle D, Benitez del Castillo JM, Amor E, et al. Severe keratomycosis secondary to Scedosporium apiospermum. Cornea 2002; 21:516.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/62\" class=\"nounderline abstract_t\">Hern&aacute;ndez Prats C, Llinares Tello F, Burgos San Jos&eacute; A, et al. Voriconazole in fungal keratitis caused by Scedosporium apiospermum. Ann Pharmacother 2004; 38:414.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/63\" class=\"nounderline abstract_t\">Nulens E, Eggink C, Rijs AJ, et al. Keratitis caused by Scedosporium apiospermum successfully treated with a cornea transplant and voriconazole. J Clin Microbiol 2003; 41:2261.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/64\" class=\"nounderline abstract_t\">Wu Z, Ying H, Yiu S, et al. Fungal keratitis caused by Scedosporium apiospermum: report of two cases and review of treatment. Cornea 2002; 21:519.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/65\" class=\"nounderline abstract_t\">del Palacio A, Perez-Blazquez E, Cu&eacute;tara MS, et al. Keratomycosis due to Scedosporium apiospermum. Mycoses 1991; 34:483.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/66\" class=\"nounderline abstract_t\">Larocco A Jr, Barron JB. Endogenous scedosporium apiospermum endophthalmitis. Retina 2005; 25:1090.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/67\" class=\"nounderline abstract_t\">Caya JG, Farmer SG, Williams GA, et al. Bilateral Pseudallescheria boydii endophthalmitis in an immunocompromised patient. Wis Med J 1988; 87:11.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/68\" class=\"nounderline abstract_t\">Figueroa MS, Fortun J, Clement A, De Ar&eacute;valo BF. Endogenous endophthalmitis caused by Scedosporium apiospermum treated with voriconazole. Retina 2004; 24:319.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/69\" class=\"nounderline abstract_t\">Leck A, Matheson M, Tuft S, et al. Scedosporium apiospermum keratomycosis with secondary endophthalmitis. Eye (Lond) 2003; 17:841.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/70\" class=\"nounderline abstract_t\">Pfeifer JD, Grand MG, Thomas MA, et al. Endogenous Pseudallescheria boydii endophthalmitis. Clinicopathologic findings in two cases. Arch Ophthalmol 1991; 109:1714.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/71\" class=\"nounderline abstract_t\">Luu KK, Scott IU, Miller D, Davis JL. Endogenous Pseudallescheria boydii endophthalmitis in a patient with ring-enhancing brain lesions. Ophthalmic Surg Lasers 2001; 32:325.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/72\" class=\"nounderline abstract_t\">Lopez FA, Crowley RS, Wastila L, et al. Scedosporium apiospermum (Pseudallescheria boydii) infection in a heart transplant recipient: a case of mistaken identity. J Heart Lung Transplant 1998; 17:321.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/73\" class=\"nounderline abstract_t\">Fort&uacute;n J, Mart&iacute;n-D&aacute;vila P, S&aacute;nchez MA, et al. Voriconazole in the treatment of invasive mold infections in transplant recipients. Eur J Clin Microbiol Infect Dis 2003; 22:408.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/74\" class=\"nounderline abstract_t\">McKelvie PA, Wong EY, Chow LP, Hall AJ. Scedosporium endophthalmitis: two fatal disseminated cases of Scedosporium infection presenting with endophthalmitis. Clin Exp Ophthalmol 2001; 29:330.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/75\" class=\"nounderline abstract_t\">Horr&eacute; R, Feil E, Stangel AP, et al. [Scedosporiosis of the brain with fatal outcome after traumatizatio of the foot. case report]. Mycoses 2000; 43 Suppl 2:33.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/76\" class=\"nounderline abstract_t\">R&uuml;chel R, Wilichowski E. Cerebral Pseudallescheria mycosis after near-drowning. Mycoses 1995; 38:473.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/77\" class=\"nounderline abstract_t\">Safdar A, Papadopoulos EB, Young JW. Breakthrough Scedosporium apiospermum (Pseudallescheria boydii) brain abscess during therapy for invasive pulmonary aspergillosis following high-risk allogeneic hematopoietic stem cell transplantation. Scedosporiasis and recent advances in antifungal therapy. Transpl Infect Dis 2002; 4:212.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/78\" class=\"nounderline abstract_t\">Montero A, Cohen JE, Fern&aacute;ndez MA, et al. Cerebral pseudallescheriasis due to Pseudallescheria boydii as the first manifestation of AIDS. Clin Infect Dis 1998; 26:1476.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/79\" class=\"nounderline abstract_t\">Mursch K, Trnovec S, Ratz H, et al. Successful treatment of multiple Pseudallescheria boydii brain abscesses and ventriculitis/ependymitis in a 2-year-old child after a near-drowning episode. Childs Nerv Syst 2006; 22:189.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/80\" class=\"nounderline abstract_t\">Chakraborty A, Workman MR, Bullock PR. Scedosporium apiospermum brain abscess treated with surgery and voriconazole. Case report. J Neurosurg 2005; 103:83.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/81\" class=\"nounderline abstract_t\">Kowacs PA, Soares Silvado CE, Monteiro de Almeida S, et al. Infection of the CNS by Scedosporium apiospermum after near drowning. Report of a fatal case and analysis of its confounding factors. J Clin Pathol 2004; 57:205.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/82\" class=\"nounderline abstract_t\">Dworzack DL, Clark RB, Borkowski WJ Jr, et al. Pseudallescheria boydii brain abscess: association with near-drowning and efficacy of high-dose, prolonged miconazole therapy in patients with multiple abscesses. Medicine (Baltimore) 1989; 68:218.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/83\" class=\"nounderline abstract_t\">Mellinghoff IK, Winston DJ, Mukwaya G, Schiller GJ. Treatment of Scedosporium apiospermum brain abscesses with posaconazole. Clin Infect Dis 2002; 34:1648.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/84\" class=\"nounderline abstract_t\">Baddley JW, Stroud TP, Salzman D, Pappas PG. Invasive mold infections in allogeneic bone marrow transplant recipients. Clin Infect Dis 2001; 32:1319.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/85\" class=\"nounderline abstract_t\">Montejo M, Mu&ntilde;iz ML, Z&aacute;rraga S, et al. Case Reports. Infection due to Scedosporium apiospermum in renal transplant recipients: a report of two cases and literature review of central nervous system and cutaneous infections by Pseudallescheria boydii/Sc. apiospermum. Mycoses 2002; 45:418.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/86\" class=\"nounderline abstract_t\">Nesky MA, McDougal EC, Peacock Jr JE. Pseudallescheria boydii brain abscess successfully treated with voriconazole and surgical drainage: case report and literature review of central nervous system pseudallescheriasis. Clin Infect Dis 2000; 31:673.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/87\" class=\"nounderline abstract_t\">Canet JJ, Pagerols X, S&aacute;nchez C, et al. Lymphocutaneous syndrome due to Scedosporium apiospermum. Clin Microbiol Infect 2001; 7:648.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/88\" class=\"nounderline abstract_t\">Karaarslan A, Arikan S, Karaarslan F, Cetin ES. Skin infection caused by Scedosporium apiospermum. Mycoses 2003; 46:524.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/89\" class=\"nounderline abstract_t\">Girmenia C, Luzi G, Monaco M, Martino P. Use of voriconazole in treatment of Scedosporium apiospermum infection: case report. J Clin Microbiol 1998; 36:1436.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/90\" class=\"nounderline abstract_t\">Schaenman JM, DiGiulio DB, Mirels LF, et al. Scedosporium apiospermum soft tissue infection successfully treated with voriconazole: potential pitfalls in the transition from intravenous to oral therapy. J Clin Microbiol 2005; 43:973.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/91\" class=\"nounderline abstract_t\">Piper JP, Golden J, Brown D, Broestler J. Successful treatment of Scedosporium apiospermum suppurative arthritis with itraconazole. Pediatr Infect Dis J 1990; 9:674.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/92\" class=\"nounderline abstract_t\">German JW, Kellie SM, Pai MP, Turner PT. Treatment of a chronic Scedosporium apiospermum vertebral osteomyelitis. Case report. Neurosurg Focus 2004; 17:E9.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/93\" class=\"nounderline abstract_t\">O'Doherty M, Hannan M, Fulcher T. Voriconazole in the treatment of fungal osteomyelitis of the orbit in the immunocompromised host. Orbit 2005; 24:285.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/94\" class=\"nounderline abstract_t\">Levine NB, Kurokawa R, Fichtenbaum CJ, et al. An immunocompetent patient with primary Scedosporium apiospermum vertebral osteomyelitis. J Spinal Disord Tech 2002; 15:425.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/95\" class=\"nounderline abstract_t\">Gatto J, Paterson D, Davis L, et al. Vertebral osteomyelitis due to Pseudallescheria boydii. Pathology 1997; 29:238.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/96\" class=\"nounderline abstract_t\">Hung LH, Norwood LA. Osteomyelitis due to Pseudallescheria boydii. South Med J 1993; 86:231.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/97\" class=\"nounderline abstract_t\">Kanafani ZA, Comair Y, Kanj SS. Pseudallescheria boydii cranial osteomyelitis and subdural empyema successfully treated with voriconazole: a case report and literature review. Eur J Clin Microbiol Infect Dis 2004; 23:836.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/98\" class=\"nounderline abstract_t\">Lonser RR, Brodke DS, Dailey AT. Vertebral osteomyelitis secondary to Pseudallescheria boydii. J Spinal Disord 2001; 14:361.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/99\" class=\"nounderline abstract_t\">Sopta J, Atanackovi&#263; M, Raspopovi&#263; V, et al. [Pseudoallescheria boydii (Scedosporium apiospermum), cause of mycotic granulomatous osteomyelitis--case diagnosis]. Srp Arh Celok Lek 2005; 133:366.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/100\" class=\"nounderline abstract_t\">Dellestable F, Kures L, Mainard D, et al. Fungal arthritis due to Pseudallescheria boydii (Scedosporium apiospermum). J Rheumatol 1994; 21:766.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/101\" class=\"nounderline abstract_t\">Fern&aacute;ndez-Guerrero ML, Ruiz Barn&eacute;s P, Al&eacute;s JM. Postcraniotomy mycetoma of the scalp and osteomyelitis due to Pseudallescheria boydii. J Infect Dis 1987; 156:855.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/102\" class=\"nounderline abstract_t\">Taj-Aldeen SJ, Rammaert B, Gamaletsou M, et al. Osteoarticular Infections Caused by Non-Aspergillus Filamentous Fungi in Adult and Pediatric Patients: A Systematic Review. Medicine (Baltimore) 2015; 94:e2078.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/103\" class=\"nounderline abstract_t\">Sampaio FM, Wanke B, Freitas DF, et al. Review of 21 cases of mycetoma from 1991 to 2014 in Rio de Janeiro, Brazil. PLoS Negl Trop Dis 2017; 11:e0005301.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/104\" class=\"nounderline abstract_t\">Mu&ntilde;oz P, Mar&iacute;n M, Tornero P, et al. Successful outcome of Scedosporium apiospermum disseminated infection treated with voriconazole in a patient receiving corticosteroid therapy. Clin Infect Dis 2000; 31:1499.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/105\" class=\"nounderline abstract_t\">Riddell J 4th, Chenoweth CE, Kauffman CA. Disseminated Scedosporium apiospermum infection in a previously healthy woman with HELLP syndrome. Mycoses 2004; 47:442.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/106\" class=\"nounderline abstract_t\">Eckburg PB, Zolopa AR, Montoya JG. Invasive fungal sinusitis due to Scedosporium apiospermum in a patient with AIDS. Clin Infect Dis 1999; 29:212.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/107\" class=\"nounderline abstract_t\">Machado CM, Martins MA, Heins-Vaccari EM, et al. Scedosporium apiospermum sinusitis after bone marrow transplantation: report of a case. Rev Inst Med Trop Sao Paulo 1998; 40:321.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/108\" class=\"nounderline abstract_t\">Kiraz N, G&uuml;lbas Z, Akg&uuml;n Y, Uzun O. Lymphadenitis caused by Scedosporium apiospermum in an immunocompetent patient. Clin Infect Dis 2001; 32:E59.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/109\" class=\"nounderline abstract_t\">Ben Hamida M, Bedrossian J, Pruna A, et al. Fungal mycotic aneurysms and visceral infection due to Scedosporium apiospermum in a kidney transplant patient. Transplant Proc 1993; 25:2290.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/110\" class=\"nounderline abstract_t\">Clement ME, Maziarz EK, Schroder JN, et al. Scedosporium apiosermum infection of the &quot;Native&quot; valve: Fungal endocarditis in an orthotopic heart transplant recipient. Med Mycol Case Rep 2015; 9:34.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/111\" class=\"nounderline abstract_t\">Rodriguez-Tudela JL, Berenguer J, Guarro J, et al. Epidemiology and outcome of Scedosporium prolificans infection, a review of 162 cases. Med Mycol 2009; 47:359.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/112\" class=\"nounderline abstract_t\">Arthur S, Steed LL, Apple DJ, et al. Scedosporium prolificans keratouveitis in association with a contact lens retained intraocularly over a long term. J Clin Microbiol 2001; 39:4579.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/113\" class=\"nounderline abstract_t\">Sullivan LJ, Snibson G, Joseph C, Taylor HR. Scedosporium prolificans sclerokeratitis. Aust N Z J Ophthalmol 1994; 22:207.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/114\" class=\"nounderline abstract_t\">Kumar B, Crawford GJ, Morlet GC. Scedosporium prolificans corneoscleritis: a successful outcome. Aust N Z J Ophthalmol 1997; 25:169.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/115\" class=\"nounderline abstract_t\">Moriarty AP, Crawford GJ, McAllister IL, Constable IJ. Fungal corneoscleritis complicating beta-irradiation-induced scleral necrosis following pterygium excision. Eye (Lond) 1993; 7 ( Pt 4):525.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/116\" class=\"nounderline abstract_t\">Taylor A, Wiffen SJ, Kennedy CJ. Post-traumatic Scedosporium inflatum endophthalmitis. Clin Exp Ophthalmol 2002; 30:47.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/117\" class=\"nounderline abstract_t\">Vagefi MR, Kim ET, Alvarado RG, et al. Bilateral endogenous Scedosporium prolificans endophthalmitis after lung transplantation. Am J Ophthalmol 2005; 139:370.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/118\" class=\"nounderline abstract_t\">Maertens J, Lagrou K, Deweerdt H, et al. Disseminated infection by Scedosporium prolificans: an emerging fatality among haematology patients. Case report and review. Ann Hematol 2000; 79:340.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/119\" class=\"nounderline abstract_t\">Lentine KL, Brennan DC, Schnitzler MA. Incidence and predictors of myocardial infarction after kidney transplantation. J Am Soc Nephrol 2005; 16:496.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/120\" class=\"nounderline abstract_t\">Nenoff P, G&uuml;tz U, Tintelnot K, et al. Disseminated mycosis due to Scedosporium prolificans in an AIDS patient with Burkitt lymphoma. Mycoses 1996; 39:461.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/121\" class=\"nounderline abstract_t\">Madrigal V, Alonso J, Bureo E, et al. Fatal meningoencephalitis caused by Scedosporium inflatum (Scedosporium prolificans) in a child with lymphoblastic leukemia. Eur J Clin Microbiol Infect Dis 1995; 14:601.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/122\" class=\"nounderline abstract_t\">Salesa R, Burgos A, Ondiviela R, et al. Fatal disseminated infection by Scedosporium inflatum after bone marrow transplantation. Scand J Infect Dis 1993; 25:389.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/123\" class=\"nounderline abstract_t\">Uno K, Kasahara K, Kutsuna S, et al. Infective endocarditis and meningitis due to Scedosporium prolificans in a renal transplant recipient. J Infect Chemother 2014; 20:131.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/124\" class=\"nounderline abstract_t\">Tamaki M, Nozaki K, Onishi M, et al. Fungal meningitis caused by Lomentospora prolificans after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis 2016; 18:601.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/125\" class=\"nounderline abstract_t\">Steinbach WJ, Schell WA, Miller JL, Perfect JR. Scedosporium prolificans osteomyelitis in an immunocompetent child treated with voriconazole and caspofungin, as well as locally applied polyhexamethylene biguanide. J Clin Microbiol 2003; 41:3981.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/126\" class=\"nounderline abstract_t\">Gosbell IB, Toumasatos V, Yong J, et al. Cure of orthopaedic infection with Scedosporium prolificans, using voriconazole plus terbinafine, without the need for radical surgery. Mycoses 2003; 46:233.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/127\" class=\"nounderline abstract_t\">Pickles RW, Pacey DE, Muir DB, Merrell WH. Experience with infection by Scedosporium prolificans including apparent cure with fluconazole therapy. J Infect 1996; 33:193.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/128\" class=\"nounderline abstract_t\">Kelly M, Stevens R, Konecny P. Lomentospora prolificans endocarditis--case report and literature review. BMC Infect Dis 2016; 16:36.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/129\" class=\"nounderline abstract_t\">Wakabayashi Y, Okugawa S, Tatsuno K, et al. Scedosporium prolificans Endocarditis: Case Report and Literature Review. Intern Med 2016; 55:79.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/130\" class=\"nounderline abstract_t\">Ochi Y, Hiramoto N, Takegawa H, et al. Infective endocarditis caused by Scedosporium prolificans infection in a patient with acute myeloid leukemia undergoing induction chemotherapy. Int J Hematol 2015; 101:620.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/131\" class=\"nounderline abstract_t\">Fernandez Guerrero ML, Askari E, Prieto E, et al. Emerging infectious endocarditis due to Scedosporium prolificans: a model of therapeutic complexity. Eur J Clin Microbiol Infect Dis 2011; 30:1321.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/132\" class=\"nounderline abstract_t\">de Batlle J, Motj&eacute; M, Balanz&agrave; R, et al. Disseminated infection caused by Scedosporium prolificans in a patient with acute multilineal leukemia. J Clin Microbiol 2000; 38:1694.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/133\" class=\"nounderline abstract_t\">Howden BP, Slavin MA, Schwarer AP, Mijch AM. Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine. Eur J Clin Microbiol Infect Dis 2003; 22:111.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/134\" class=\"nounderline abstract_t\">Marin J, Sanz MA, Sanz GF, et al. Disseminated Scedosporium inflatum infection in a patient with acute myeloblastic leukemia. Eur J Clin Microbiol Infect Dis 1991; 10:759.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/135\" class=\"nounderline abstract_t\">Rabodonirina M, Paulus S, Thevenet F, et al. Disseminated Scedosporium prolificans (S. inflatum) infection after single-lung transplantation. Clin Infect Dis 1994; 19:138.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/136\" class=\"nounderline abstract_t\">Bouza E, Mu&ntilde;oz P, Vega L, et al. Clinical resolution of Scedosporium prolificans fungemia associated with reversal of neutropenia following administration of granulocyte colony-stimulating factor. Clin Infect Dis 1996; 23:192.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/137\" class=\"nounderline abstract_t\">Spielberger RT, Tegtmeier BR, O'Donnell MR, Ito JI. Fatal Scedosporium prolificans (S. inflatum) fungemia following allogeneic bone marrow transplantation: report of a case in the United States. Clin Infect Dis 1995; 21:1067.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/138\" class=\"nounderline abstract_t\">De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46:1813.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/139\" class=\"nounderline abstract_t\">Tarrand JJ, Lichterfeld M, Warraich I, et al. Diagnosis of invasive septate mold infections. A correlation of microbiological culture and histologic or cytologic examination. Am J Clin Pathol 2003; 119:854.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/140\" class=\"nounderline abstract_t\">Pryce TM, Palladino S, Price DM, et al. Rapid identification of fungal pathogens in BacT/ALERT, BACTEC, and BBL MGIT media using polymerase chain reaction and DNA sequencing of the internal transcribed spacer regions. Diagn Microbiol Infect Dis 2006; 54:289.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/141\" class=\"nounderline abstract_t\">Lionakis MS, Bodey GP, Tarrand JJ, et al. The significance of blood cultures positive for emerging saprophytic moulds in cancer patients. Clin Microbiol Infect 2004; 10:922.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/142\" class=\"nounderline abstract_t\">de Aguirre L, Hurst SF, Choi JS, et al. Rapid differentiation of Aspergillus species from other medically important opportunistic molds and yeasts by PCR-enzyme immunoassay. J Clin Microbiol 2004; 42:3495.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/143\" class=\"nounderline abstract_t\">Ruiz-D&iacute;ez B, Mart&iacute;n-D&iacute;ez F, Rodr&iacute;guez-Tudela JL, et al. Use of random amplification of polymorphic DNA (RAPD) and PCR-fingerprinting for genotyping a Scedosporium prolificans (inflatum) outbreak in four leukemic patients. Curr Microbiol 1997; 35:186.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/144\" class=\"nounderline abstract_t\">Harun A, Blyth CC, Gilgado F, et al. Development and validation of a multiplex PCR for detection of Scedosporium spp. in respiratory tract specimens from patients with cystic fibrosis. J Clin Microbiol 2011; 49:1508.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/145\" class=\"nounderline abstract_t\">Lu Q, Gerrits van den Ende AH, Bakkers JM, et al. Identification of Pseudallescheria and Scedosporium species by three molecular methods. J Clin Microbiol 2011; 49:960.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/146\" class=\"nounderline abstract_t\">Steinmann J, Schmidt D, Buer J, Rath PM. Discrimination of Scedosporium prolificans against Pseudallescheria boydii and Scedosporium apiospermum by semiautomated repetitive sequence-based PCR. Med Mycol 2011; 49:475.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/147\" class=\"nounderline abstract_t\">Castelli MV, Buitrago MJ, Bernal-Martinez L, et al. Development and validation of a quantitative PCR assay for diagnosis of scedosporiosis. J Clin Microbiol 2008; 46:3412.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/148\" class=\"nounderline abstract_t\">Odabasi Z, Paetznick VL, Rodriguez JR, et al. Differences in beta-glucan levels in culture supernatants of a variety of fungi. Med Mycol 2006; 44:267.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/149\" class=\"nounderline abstract_t\">Odabasi Z, Mattiuzzi G, Estey E, et al. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 2004; 39:199.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/150\" class=\"nounderline abstract_t\">Ostrosky-Zeichner L, Alexander BD, Kett DH, et al. Multicenter clinical evaluation of the (1--&gt;3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis 2005; 41:654.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/151\" class=\"nounderline abstract_t\">Pazos C, Pont&oacute;n J, Del Palacio A. Contribution of (1-&gt;3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan. J Clin Microbiol 2005; 43:299.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/152\" class=\"nounderline abstract_t\">Yoshida M, Obayashi T, Iwama A, et al. Detection of plasma (1 --&gt; 3)-beta-D-glucan in patients with Fusarium, Trichosporon, Saccharomyces and Acremonium fungaemias. J Med Vet Mycol 1997; 35:371.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/153\" class=\"nounderline abstract_t\">Ziesing S, Suerbaum S, Sedlacek L. Fungal epidemiology and diversity in cystic fibrosis patients over a 5-year period in a national reference center. Med Mycol 2016; 54:781.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/154\" class=\"nounderline abstract_t\">Bernhard M, Zautner AE, Steinmann J, et al. Towards proteomic species barcoding of fungi - An example using Scedosporium/Pseudallescheria complex isolates. Fungal Biol 2016; 120:162.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/155\" class=\"nounderline abstract_t\">Sitterl&eacute; E, Giraud S, Leto J, et al. Matrix-assisted laser desorption ionization-time of flight mass spectrometry for fast and accurate identification of Pseudallescheria/Scedosporium species. Clin Microbiol Infect 2014; 20:929.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/156\" class=\"nounderline abstract_t\">Sleiman S, Halliday CL, Chapman B, et al. Performance of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Identification of Aspergillus, Scedosporium, and Fusarium spp. in the Australian Clinical Setting. J Clin Microbiol 2016; 54:2182.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-scedosporium-and-lomentospora-infections/abstract/157\" class=\"nounderline abstract_t\">Liu K, Howell DN, Perfect JR, Schell WA. Morphologic criteria for the preliminary identification of Fusarium, Paecilomyces, and Acremonium species by histopathology. Am J Clin Pathol 1998; 109:45.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 2424 Version 10.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H21\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">MYCOLOGY</a><ul><li><a href=\"#H3\" id=\"outline-link-H3\">Scedosporium apiospermum complex</a></li><li><a href=\"#H4\" id=\"outline-link-H4\">Lomentospora (formerly Scedosporium) prolificans</a></li></ul></li><li><a href=\"#H5\" id=\"outline-link-H5\">EPIDEMIOLOGY</a></li><li><a href=\"#H6\" id=\"outline-link-H6\">COLONIZATION</a></li><li><a href=\"#H7\" id=\"outline-link-H7\">CLINICAL MANIFESTATIONS</a><ul><li><a href=\"#H8\" id=\"outline-link-H8\">S. apiospermum infections</a><ul><li><a href=\"#H9\" id=\"outline-link-H9\">- Respiratory tract</a></li><li><a href=\"#H10\" id=\"outline-link-H10\">- Keratitis and endophthalmitis</a></li><li><a href=\"#H11\" id=\"outline-link-H11\">- Central nervous system</a></li><li><a href=\"#H12\" id=\"outline-link-H12\">- Skin, soft tissue, and bone</a></li><li><a href=\"#H13\" id=\"outline-link-H13\">- Disseminated infection</a></li><li><a href=\"#H14\" id=\"outline-link-H14\">- Other</a></li></ul></li><li><a href=\"#H334471836\" id=\"outline-link-H334471836\">S. aurantiacum infections</a></li><li><a href=\"#H15\" id=\"outline-link-H15\">L. prolificans infections</a><ul><li><a href=\"#H16\" id=\"outline-link-H16\">- Respiratory tract</a></li><li><a href=\"#H17\" id=\"outline-link-H17\">- Keratitis and endophthalmitis</a></li><li><a href=\"#H18\" id=\"outline-link-H18\">- Central nervous system</a></li><li><a href=\"#H19\" id=\"outline-link-H19\">- Skin, soft tissue, and bone infections</a></li><li><a href=\"#H1992817663\" id=\"outline-link-H1992817663\">- Endocarditis</a></li><li><a href=\"#H20\" id=\"outline-link-H20\">- Disseminated infection</a></li></ul></li></ul></li><li><a href=\"#H863185604\" id=\"outline-link-H863185604\">DIAGNOSIS</a><ul><li><a href=\"#H1119797472\" id=\"outline-link-H1119797472\">Approach to diagnosis</a></li><li><a href=\"#H1119797400\" id=\"outline-link-H1119797400\">Diagnostic techniques</a><ul><li><a href=\"#H863185641\" id=\"outline-link-H863185641\">- Histopathology</a></li><li><a href=\"#H863185689\" id=\"outline-link-H863185689\">- Culture</a></li></ul></li><li><a href=\"#H863186180\" id=\"outline-link-H863186180\">Molecular techniques</a></li><li><a href=\"#H863186274\" id=\"outline-link-H863186274\">Antigen detection</a></li><li><a href=\"#H3611839638\" id=\"outline-link-H3611839638\">MALDI-TOF</a></li></ul></li><li><a href=\"#H863186356\" id=\"outline-link-H863186356\">DIFFERENTIAL DIAGNOSIS</a></li><li><a href=\"#H21\" id=\"outline-link-H21\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"ID/2424|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=ID/52899\" class=\"graphic graphic_picture\">- Scedosporium and Lomentospora cultures</a></li><li><a href=\"image.htm?imageKey=ID/74529\" class=\"graphic graphic_picture\">- Scedosporium apiospermum microscopy</a></li><li><a href=\"image.htm?imageKey=ID/62333\" class=\"graphic graphic_picture\">- Pseudallescheria boydii microscopy</a></li><li><a href=\"image.htm?imageKey=ID/63775\" class=\"graphic graphic_picture\">- Lomentospora prolificans microsopy</a></li></ul></li><li><div id=\"ID/2424|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=ID/52154\" class=\"graphic graphic_table\">- Diagnosis of Scedosporium and Lomentospora infections</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=antifungal-susceptibility-testing\" class=\"medical medical_review\">Antifungal susceptibility testing</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diagnosis-of-invasive-aspergillosis\" class=\"medical medical_review\">Diagnosis of invasive aspergillosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-scedosporium-and-lomentospora-infections\" class=\"medical medical_review\">Treatment of Scedosporium and Lomentospora infections</a></li></ul></div></div>","javascript":null}